Comgest Growth Europe GBP U AccRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | -15.6 | 20.8 | 7.8 | |
+/-Cat | - | - | 0.4 | 7.4 | 3.3 | |
+/-B’mrk | - | - | -2.6 | 7.4 | 2.1 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: MSCI Europe Growth NR EUR |
Key Stats | ||
NAV 27/03/2024 | GBP 12.31 | |
Day Change | 0.08% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
IA (formerly IMA) Sector | Europe Including UK | |
ISIN | IE00BK5X4782 | |
Fund Size (Mil) 27/03/2024 | EUR 6510.88 | |
Share Class Size (Mil) 27/03/2024 | GBP 1.99 | |
Max Initial Charge | - | |
Ongoing Charge 20/02/2023 | 1.05% |
Morningstar Research |
Analyst Report | 20/09/2023 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 25 |
Parent | 24 |
Process | 25 |
Performance | |
Price |
Investment Objective: Comgest Growth Europe GBP U Acc |
The investment objective of the Fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in Europe. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 01/11/2009 | ||
Pierre Lamelin 28/02/2022 | ||
Click here to see others | ||
Inception Date 30/09/2021 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | MSCI Europe Growth NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe GBP U Acc | 30/11/2023 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 8.06 |
ASML Holding NV | Technology | 7.34 |
Essilorluxottica | Healthcare | 4.68 |
Accenture PLC Class A | Technology | 4.63 |
Linde PLC | Basic Materials | 4.36 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe GBP U Acc |